Mekonos, a company working towards cell engineering on a chip, has entered into a partnership agreement with Accelerated Bio to codevelop a new manufacturing cell line based on Accelerated Bio’s human Trophoblast Stem Cells (hTSCs) and Gene Engineered Multi-Sites (GEMS) technology. Dr Anil Narasimha, Co-founder and Chief… Read More
This paid-for advertorial by Sphere Fluidics appeared in the SLAS 2023 Supplement, Volume 24 – Issue 1, Winter 2022/2023 Cell engineering is being held back by lengthy and complicated multi-step workflows. Sphere Fluidics’ Cyto-Mine® system offers a streamlined, automated solution to this challenge using picodroplet microfluidic technology. Cell engineering is bringing… Read More
CRISPR-based knockouts are the gold-standard genetic perturbation method in target identification and validation. However, efficient CRISPR knockout editing and transfection for arrayed screening require specialised skills and infrastructure that your organisation may not have. What if you could receive ready-to-use CRISPR-edited cells without needing to handle, optimise, and transfect your… Read More
Provider of high-performance life science solutions Molecular Devices has celebrated the one-year anniversary of its automated 3D imaging workcell, the Organoid Innovation Center with the expansion of new cell engineering capabilities. Located at the company’s global headquarters, the Organoid Innovation Center helps researchers automate sample prep… Read More
